HomeRVMD • NASDAQ
Revolution Medicines Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 35.01M | 53.30% |
Net income | -213.42M | -83.97% |
Net profit margin | — | — |
Earnings per share | -1.13 | -61.43% |
EBITDA | -239.10M | -71.58% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.10B | 23.43% |
Total assets | 2.37B | 23.95% |
Total liabilities | 287.20M | 57.03% |
Total equity | 2.08B | — |
Shares outstanding | 186.27M | — |
Price to book | 3.47 | — |
Return on assets | -24.45% | — |
Return on capital | -26.09% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -213.42M | -83.97% |
Cash from operations | -194.44M | -21.10% |
Cash from investing | -15.95M | 93.57% |
Cash from financing | 874.00K | 7.90% |
Net change in cash | -209.51M | 48.61% |
Free cash flow | -123.94M | -1.18% |
Previous close
$38.74
Day range
$38.24 - $39.04
Year range
$29.17 - $62.40
Market cap
7.16B USD
Avg Volume
1.96M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Headquarters
Website
Employees
616
